LIDDE Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis (NCT04696666) | LIDDE Therapeutics | 2020-05-15 |
Track LIDDE Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.